3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?
One great thing about the biotech industry is that there are nearly always some winners. Regardless of what's going on in the world or in the broader market, at least a few biotech stocks are likely to gain momentum week in and week out.
Three such winners over the past five days are Madrigal Pharmaceuticals (NASDAQ: MDGL), Alnylam Pharmaceuticals (NASDAQ: ALNY), and Arbutus Biopharma (NASDAQ: ABUS). Here's why these three biotech stocks skyrocketed this week -- and a look at whether or not they can go even higher.
Image source: Getty Images.
Source: Fool.com
Sanofi S.A. ADR Aktie
49,40 €
1,23 %
Positive Tendenz für Sanofi S.A. ADR mit mehreren Buy- und keiner Sell-Einschätzung.
Mit einem Kursziel von 55 € für Sanofi S.A. ADR ist ein leichter Anstieg gegenüber dem aktuellen Kurs von 49.4 € zu erwarten.
